Skip to main content
Fig. 3 | BMC Nephrology

Fig. 3

From: Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection

Fig. 3

Crude and adjusted estimation of eGFR according to GEE longitudinal models. Crude model (a); adjusted by graft loss (b); adjusted by IFTA (interstitial fibrosis and tubular atrophy) and MVI (microvascular inflammation) (c); adjusted by age and Charlson comorbidity index (d); adjusted by proteinuria (e); adjusted by glomerulitis, capillaritis and transplant glomerulopathy (f); adjusted by infection disease complications in the follow-up (g). Estimated glomerular filtrate rate (eGFR)

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us